Program

Current as of Friday 29 July 2026, and is subject to change.

AMC 2026 — Program at a Glance

The AMC 2026 program features a broad range of speakers across multiple disciplines and concurrent sessions, organised under four key themes:

Prevention Early Detection Advanced Disease Survivorship

How to read this program

Plenary Concurrent Panel Discussion Late breaking Break Social event Oral abstract

Thursday 19 November · Day 1 · Pre-Conference

8:00 AM – 5:00 PM9 hrs
MASC Trials Scientific Meeting
Sofitel Melbourne on Collins
3:00 PM – 6:30 PM3.5 hrs
Registration for AMC 2026 Open
Sofitel Melbourne on Collins · Registration Desk
5:00 PM – 6:30 PM90 mins
Welcome Networking Reception
Sofitel Melbourne on Collins
 Social

Friday 20 November · Day 2 · Main Program

7:00 AM – 6:00 PM11 hrs
Registration Open
Sofitel Melbourne on Collins · Registration Desk
7:00 AM – 8:00 AM60 mins
Breakfast Workshop
Sofitel Melbourne on Collins
 Break
8:00 AM – 9:30 AM90 mins
Invited Speakers: Eugene Semenov, Vivek Naranbhai
9:30 AM – 11:00 AM90 mins
UK experience with AI-assisted triage
Rubeta Matin
Invited Speaker
Legal and regulatory considerations when using AI in clinical practice
Lisa Abbott
Invited Speaker
Using scribes in practice
Steve Salerno
Invited Speaker
Imaging AI in Skin Cancer Practice
John Prossor
Invited Speaker
Defining a targeted approach to skin tox
Eugene Semenov
Invited Speaker
Polygenic risk for idiopathic Inflammatory Bowel Disease predicts severe colitis following Immune Checkpoint Blockade in advanced melanoma
Hadis Ghajari
Oral Abstract
Circulating Antibody Profiling Identifies Predictive Biomarkers of Outcome and irAEs in Melanoma
Joanna Chan
Oral Abstract
9:30 – 9:35Achieving Equity for Patients
Chair: Olivia Cook
9:35 – 10:00Reducing barriers to care for rural patients
Expanding Access to Specialist Skin Cancer Care: Supporting Rural Patients and the Evolving Role of Skin Cancer Nurses
Emma Zurawel, Melissa Sheldon
Invited Speaker
MDT perspectives on specialist melanoma nurse role integration and system-level impact across a national program
Rebecca Johnson
Oral Abstract
10:00 – 10:50When Treatment Becomes the Challenge: Severe Multisystem Immunotherapy Complications in Advanced Melanoma
Panel discussion — lead Andrew Haydon
Case Study
Andrew Haydon
Panel Discussion
Patient Video
Faecal Microbiota Transplantation (FMT) as a treatment for colitis
Steven Nicolaides
Panel Discussion
Diet Therapy for ICI Colitis, Exclusive Enteral Nutrition Project
Jessica Fitzpatrick
Panel Discussion
Complexities of Melanoma Nurse Management: Preparing the Workforce for Current and Emerging Therapies
Donna Milne
Panel Discussion
10:50 – 11:00Q & A
11:00 AM – 11:30 AM30 mins
Morning Tea
Exhibition Hall
 Break
11:30 AM – 1:00 PM90 mins
Changing the advertising code one submission at a time
Anne Gately
Invited Speaker
What does it take to reach an audience with a media campaign in times of distraction
Camilla Hercus
Invited Speaker
Art and science: The power of 'The Spot'
Tamara Dawson
Invited Speaker
Panel Discussion
Panel Discussion
Invited Speakers: Tony Caccetta, Vivienne Milch, Dan Lindsay, Peter Gourlay, Louise Jackett
Environmentally stressed drug-naive melanoma cells share a molecular signature with drug-tolerant and drug-resistant cells
Nikolas Hass
Invited Speaker
Vivian Chua
Invited Speaker
Thomas Gebhart
Invited Speaker
Spatial transcriptomics reveals distinct cellular niches of resistance to immune checkpoint blockade in melanoma
Xiaohang Fu
Oral Abstract
Identification of metabolic phenotypes associated with prognosis and therapeutic response in patients with melanoma (MetaMel Study)
Thomas Breakell
Oral Abstract
1:00 PM – 2:00 PM60 mins
Lunch
Exhibition Hall
 Break
2:00 PM – 3:30 PM90 mins
Molecular evidence of UV causation at cellular level
Hunter Shain
Invited Speaker
Sunscreen labelling and what consumers understand
Anna Nicholson
Invited Speaker
Sunscreen and Vitamin D: results from the Sun-D Trial
Rachael Neale
Invited Speaker
TBA - Molecular Causation
Amaya Viros
Invited Speaker
Spectral composition of ambient ultraviolet radiation and melanoma incidence across Australia
Catherine Olsen
Oral Abstract
Panel Discussion
Chair: Craig Sinclair
Panel Discussion
Should we perform skin checks
Linda Martin and Mostafa Khalafalla
Invited Speaker
Margins for invasive melanoma
Alexander van Akooi and David Speakman
Invited Speaker
Selective lymph node resection vs total lymphadenectomy after neoadjuvant drug therapy
Thomas Pennington and Michael Hughes
Invited Speaker
Adjuvant immunotherapy for sentinel node positive disease
Lavinia Spain
Invited Speaker
Can less be more? Exploring consumer and clinician perspectives on deintensification in melanoma using digital democracy tools
Jennifer Soon
Oral Abstract
Mind the Gap: Impact of new labels on public perceptions and calculated risk of adverse outcomes after a melanoma in-situ diagnosis
Zhuohan Wu
Oral Abstract
RADICAL Trial: results, cosmetic, patient-reported outcomes, and health economic synthesis; what's next?
Pascale Guitera
Oral Abstract
Eugene Semenov
Invited Speaker
Precision diagnostics for early melanoma detection using spatial biology and AI-guided image analysis
Mitch Stark
Oral Abstract
Clinical and pathological characteristics of thin cutaneous melanomas with rapid recurrence
Prachi Bhave
Oral Abstract
Single-cell transcriptomic analysis of melanoma sentinel lymph nodes following pre-operative propranolol in a placebo-controlled, randomised trial
Nicholas Muller
Oral Abstract
Early Detection of Melanoma Using Circulating Tumour-specific Antibodies
Tawany De Carvalho Gil
Oral Abstract
Development and validation of a deep learning model with enhanced explainability for interpreting melanocytic tumour pathologies
Nigel Maher
Oral Abstract
3:30 PM – 4:00 PM30 mins
Afternoon Tea
Exhibition Hall
 Break
4:00 PM – 5:00 PM60 mins
Invited Speakers: Hunter Shain, Rachael Neale
5:00 PM – 6:00 PM60 mins
Panel Discussion
Panellists: Tiffany Cherry, Grace Brown & Peter Soyer
Panel Discussion
7:00 PM – 10:00 PM3 hrs
Conference Networking Dinner
Melbourne Cricket Ground (MCG)
 Social

Saturday 21 November · Day 3 · Main Program

7:30 AM – 4:00 PM8.5 hrs
Registration Open
Sofitel Melbourne on Collins · Registration Desk
7:30 AM – 8:30 AM60 mins
Breakfast Workshop
Sofitel Melbourne on Collins
 Break
8:30 AM – 10:30 AM120 mins
Sunscreen: the burning topic in 2026
Rachel Neale
Invited Speaker
What could the future of skin checks look like (ACEMID, AI)
Victoria Mar
Invited Speaker
The landscape is changing rapidly with new medicines for melanoma and skin cancer. What's new and what's on the horizon?
Grant McArthur
Invited Speaker
Advocacy Workshop — What does good advocacy look like? How can we use our lived experience to create change? How can you make your voice heard?
Melissa Sheldon, Peter Gourlay, Craig Lawn, Pauline Ryan, Anne Gately
Invited Speaker
Invited Speakers: George Pratt, Hugh Roberts, Mostafa Khalafalla, Pascale Guitera, Alan Pham
TIL therapy - Iovance experience
Adnan Khattak
Invited Speaker
T Cell Engagers -will that be a clinical data
Damien Kee
Invited Speaker
TIL and tissue microenvironment engineering
Hannah Newness
Invited Speaker
Microbiome - T cell metabolism
Annabell Bachem
Invited Speaker
Immune Cell Dynamics and Outcomes in Neoadjuvant-Treated Stage III Melanoma
Tina Hieken
Oral Abstract
10:30 AM – 11:00 AM30 mins
Morning Tea
Exhibition Hall
 Break
11:00 AM – 12:00 PM60 mins
Invited Speakers: Amaya Viros, Jergen Becker
12:00 PM – 12:30 PM30 mins
Highest-ranked late-breaking abstract submissions
12:30 PM – 1:30 PM60 mins
Lunch
Exhibition Hall
 Break
1:30 PM – 3:30 PM120 mins
Update from the national targeted melanoma screening roadmap
Anne Cust
Invited Speaker
Modelling a potential screeing program
Dan Lindsay
Invited Speaker
GP perspectives on a potential screening program
Solange Green
Invited Speaker
ACEMID cohort characteristics and excision outcomes
Simone Goldinger
Invited Speaker
Embedding skin cancer prevention in melanoma screening: SunSmart in ACEMID pilot results
Anna Nicholson
Oral Abstract
Additional risk loci and a comprehensive polygenic risk score for melanoma from the largest GWAS to date: Towards melanoma risk based screening
Jayasinghe
Oral Abstract
Factors associated with a diagnosis of thick invasive melanoma: findings from the QSkin prospective cohort
Nirmala Pandeya
Oral Abstract
Cardiovascular Risk in Long-Term Melanoma Survivorship after Immunotherapy
Sean Tan
Invited Speaker
The Role of Exercise in Patients Receiving Immunotherapy
Eva Zopf
Invited Speaker
Beyond Survival: Caring for the Psychological Impact of Melanoma
Claire Gore
Invited Speaker
Towards Safe Discontinuation of Immune Checkpoint Inhibitor Therapy: Integrating Digital Pathology and Gene Profiling in Melanoma
Oana-Diana Persa
Oral Abstract
The melanoma school: safe and effective discharge of early-stage melanoma patients to community care
Edward Clarke
Oral Abstract
MPA nurse-led survivorship service and role in providing survivorship care beyond the acute setting
Peta Holly
Oral Abstract
Panel Discussion
Panellists: Richard Kelly, Danielle Goss, Julie Teraci, Justin Tse, Karen van Gorp & Tamara Dawson
Panel Discussion
Mechanisms of tumorigenesis in acral melanoma
Yeye Guo
Invited Speaker
Nail apparatus melanoma with comparison of biopsy technique
Cliff Rosendahl
Invited Speaker
Ocular/periocular melanoma: histopathologic challenges
Penny McElvie
Invited Speaker
Periocular melanoma: Management challenges
Alex Chamberlain
Invited Speaker
Ocular melanoma: diagnostic and therapeutic challenges
Rod O'Day
Invited Speaker
Ocular melanoma therapies and clinical trials
Mal Ameratunga
Invited Speaker
Targeting Epigenetic Enzymes in Metastatic Uveal Melanoma
Jason Lee
Oral Abstract
3:30 PM – 4:15 PM45 mins
Invited Speakers: Georgina Long, Adnan Khattak
4:15 PM – 4:30 PM15 mins
Closing Remarks
Sofitel Melbourne on Collins
AMC 2026 · Australasian Melanoma Conference · Sofitel Melbourne on Collins · 19–21 November 2026
Program subject to change. Accurate as of 6 July 2026.